Navigation Links
Aida Announces New Anti-Cancer Drug Under Development
Date:4/18/2008

SANTA MONICA, Calif., April 18 /PRNewswire-FirstCall/ -- Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) (hereinafter referred to as "Aida") today announced that it is developing a potential cancer drug that seeks to trigger cell death in certain types of cancer. Vasostatin-Apo2L, a pre-clinical product being developed by Aida's Shanghai Qiaer subsidiary, is a recombinant fusion protein that integrates the function of extracted fragments of Vasostatin, an inhibitor of angiogenesis and tumor growth, with the function of Rh-Apo2L, which induces the apoptosis of cancer cells. It has shown positive results in the lab. Aida's researchers believe that the integration of Vasostatin-Apo2L will have higher efficacy in certain cancer treatments than currently prescribed methods.

Aida estimates that Vasostatin will have a target market of 80,000-100,000 patients per year after it is successfully brought to market and this will contribute significantly to Aida's revenue.

Vasostatin-Apo2L is developed by the same research team that created Rh-Apo2L. Rh-Apo2L has successfully completed its Phase 2 clinical testing and is going to file application with the PRC government's State Food and Drug Administration to start the Phase III trials. The development of Vasostatin-Apo2L will benefit strongly from the experience garnered in the research, manufacturing and distribution of Rh-Apo2L.

About Aida Pharmaceuticals

Aida Pharmaceuticals is a product-focused pharmaceuticals company engaged in the formulation, clinical testing, registration, manufacture, sales and marketing of advanced pharmaceutical and genetic products in mainland China. The Company's mission is to discover, develop and market meaningful new therapies that improve human health. Aida Pharmaceuticals, in operation since March 1999, is headquartered in Hangzhou, China with manufacturing, distribution and sales points throughout mainland China. Aida is GMP certified in China and ISO90
'/>"/>

SOURCE Aida Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ov.24/PRNewswire-Asia/--ChindexInternational,Inc.,...icanproviderofWestern,healthcareproductsandservice...heCompanywillattendthe21stAnnualPiperJaffray,"Unpl...9,atthe,NewYorkPalaceHotel. , Managementiscur...mber1,2009,andholdone-on-onemeetingsthroughoutthed...
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--Endologix,Inc.(Nasda...raorticdisorders,announcedtodaythatithasfiledamoti...fringementlawsuitbroughtagainstitinOctober2009byCo...ourtinIndianapolis,Indiana. ,, Endologixhasrequ...PatentandTrademarkOffice(USPTO)conductsproceedings...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRM...nofReorganizationandDisclosureStatementtoday,Novem...eDistrictofDelaware.Ahearingtoconsiderapprovalofth...r8,2009,withthehearingontheconfirmationofthePlansc...ompanytopayallclaimsinfull.ThePlanisexpected,ifapp...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Minnesota Chiropractic Leader Earns National Recognition 59173 1Breast Specific Gamma Imaging Proves Cost Effective for Pre Surgical Planning of Patients with Known Cancer Diagnosis 5357 1Breast Specific Gamma Imaging Proves Cost Effective for Pre Surgical Planning of Patients with Known Cancer Diagnosis 5357 2Hanger Orthopedic Group Inc Announces Three Acquisitions Totaling 2410 7 Million of Annual Net Revenue 5353 1Hanger Orthopedic Group Inc Announces Three Acquisitions Totaling 2410 7 Million of Annual Net Revenue 5353 2
(Date:11/26/2009)...sequestering drug tetrathiomolybdate (TM) has been... of Wilson disease, a disease caused by an overloa...much is known. Very little, however, is known abou... new study led by Northwestern University research...-dimensional structure of TM bound to copper-loade...
(Date:11/26/2009)... No more letters from the North Pole, ...d text messages from Santa , ...ease operational efficiencies at the North Pole Sa...p children all over the globe informed of his Chri...ta’s research department have identified a l...
(Date:11/26/2009)... Benton Communications announces a hig...ystem for retailers struggling to make an economic...mber 26, 2009 -- Flu fears is the type of challeng...gency room, according to Dr. David Benton, busines...usiness growth system – The Rfactor Intensi...
(Date:11/25/2009)...SCITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConvent...dicalcliniconDec.9-10,whenKansasCityhoststhelatest..., "Thisfreecliniceventhasthepotentialtobethebig...justoneandbeheldonweekdaysinsteadofoveraweekend,"S...hClinicandpresidentoftheNationalAssociationofFreeC...
(Date:11/25/2009)...TO,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadi...tionsoftwarelaunchesasuiteofnewleadingedgeclinical...atformatthisyear,sRadiologicalSocietyofNorthAmeric...oth5800,HallA).Theapplicationsleveragetheuniquehig...Iimagingcoilsandsupportmultipleimagingmodalitiesfo...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3
...ARAMUS, N.J., July 31 Smart Balance Inc.,(Nasdaq:... organization,today. Richard McWilliams has been n... manager, core brands, reporting to Gregory Venner..., "Richard will be a valuable addition to the Sma...
... ANN ARBOR, Mich. Pat Phalin learned she had hea...ing tests at her local school. The pupils heard so...genealogy enthusiast, saw a pattern in his wife,s ...ore he reached school age. , The hearing loss mu...
...T. LOUIS, July 31 Stereotaxis, Inc. (Nasdaq:,STXS...al results for the,second quarter ended June 30, 2...opens. The Company will host a conference call and...dial-in,number for the conference call is 800-240-...
...EATTLE, July 31 Trubion Pharmaceuticals Inc.,(Nas...e earnings results for,second quarter and first si...arket on Aug. 7, 2008. The company,s earnings conf.../investors.trubion.com/events.cfm ., Second Quart...
... Television commercials are a common method for a...niversity of Alberta researchers, these food adver..., especially university students. , "The transiti...se and decreases in physical activity and fruit an...
... SANTA ROSA, Calif., July 30, 2008 While summer ...heir day outside, summer allergens keep many sinus...uing, hanging out at the pool and spending time in...cial outings or business engagements because of th...
Other Medicine News:Health News:Smart Balance Announces Marketing Organization Appointment 2Health News:Inherited form of hearing loss stems from gene mutation 2Health News:Inherited form of hearing loss stems from gene mutation 3Health News:Trubion Pharmaceuticals Provides Announcement Dates for Second Quarter and First Six Months Earnings Conference Call 2Health News:Watching too much TV is causing some university students to pack on the pounds 2Health News:Sinus sufferers miss out on work or social activities due to summer allergies 2
Macular Plus 5.5
Super Vitreofundus
Superfield NC
Quadr Aspheric
Medicine Products: